Nath Bio-Genes Market Cap ($28.36M USD)
Nath Bio-Genes Market Cap ($28.36M USD). As of Oct. 6, 2026, Nath Bio-Genes (NATHBIOGEN) market capitalisation is ₹255.20 Cr ($28.36M), with 1.85 Cr shares outstanding at a current price of ₹138.31 on NSE, ranking 2366 out of 5368 companies by market cap in our screener. Nath Bio-Genes operates in the FMCG sector and is classified as a Small Cap stock. Compare with NATHBIOGEN fair value estimate to assess whether the stock is under or overvalued.
Market Cap History of Nath Bio-Genes (Last 10 Years)
NATHBIOGEN market capitalisation from year-end NSE closing prices over the last 10 years. For live price, earnings and the complete company profile, see Nath Bio-Genes share price screener.
End of Year Market Cap History — Nath Bio-Genes
NATHBIOGEN year-end market cap in INR and USD with closing share price and annual change — NSE closing prices. Examine Nath Bio-Genes quarterly earnings for recent quarterly revenue, profit and EPS trends.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹255.20 Cr
$28.36M USD
|
₹138.31 | NSE | -11.05% |
| 2025 |
₹286.90 Cr
$31.88M USD
|
₹155.49 | NSE | -17.36% |
| 2024 |
₹347.16 Cr
$38.57M USD
|
₹188.15 | BSE | -9.26% |
| 2023 |
₹382.59 Cr
$42.51M USD
|
₹207.35 | BSE | +28.31% |
| 2022 |
₹298.17 Cr
$33.13M USD
|
₹161.60 | BSE | -39.06% |
| 2021 |
₹489.33 Cr
$54.37M USD
|
₹265.20 | BSE | -3.51% |
| 2020 |
₹507.13 Cr
$56.35M USD
|
₹274.85 | BSE | -20.40% |
| 2019 |
₹637.12 Cr
$70.79M USD
|
₹345.30 | BSE | -16.94% |
| 2018 |
₹767.02 Cr
$85.22M USD
|
₹415.70 | BSE | -10.10% |
| 2017 |
₹853.19 Cr
$94.80M USD
|
₹462.40 | BSE | +212.43% |
| 2016 |
₹273.08 Cr
$30.34M USD
|
₹148.00 | BSE | +89.99% |
| 2015 |
₹143.74 Cr
$15.97M USD
|
₹77.90 | BSE | -38.59% |
| 2014 |
₹234.05 Cr
$26.01M USD
|
₹126.85 | BSE | - |